Project Grant HT94252510618
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$426K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The U.S. Department of Defense's Defense Health Agency awarded a $393,416 Project Grant to the Board of Regents of the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2026, will support UNMC's research on the "Influence of Ocular Blast Injury on Retinal Output Synapses in the Brain". This project aims to advance the understanding of the...
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...
The $309,086 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the Centre for Eye Research Australia Limited (operating as the University of Melbourne Department of Ophthalmology) to target NADPH oxidase 4 to reduce ocular scarring following chemical burns to the eye. The project will run from July 2025 to June 2027 and aims to develop innovative medical treatments to address this critical eye...
This $4,626,921 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The grant was awarded on August 1, 2025 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization in Bethesda, Maryland. The research aims to elucidate the role of the...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $869,193 to the University of Chicago to conduct research on identifying the pathogenesis of monosomy 7 in bone marrow failure. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical discoveries in this specialized medical domain. The award has a performance period...
The federal Project Grant award of $200,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The award, effective July 1, 2025 through June 30, 2027, will enable Northwestern University's researchers to investigate this critical medical challenge and develop innovative solutions to transform healthcare for military...
This federal Project Grant award of $410,800 from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) is supporting the "Restoration of Visual Function Using Optic Nerve Relays" research project at the University of California, San Diego (UCSD). The project aims to advance medical solutions and healthcare for military service members and the general public through innovative biomedical research in neuroscience and vision restoration....
This $626,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports Emory University's research on developing immune-competent 3D bioprinted organoids to study and target barriers to cellular therapy for neuroblastoma. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions. The 2-year award period runs from July 15, 2025 to July...
The U.S. Defense Health Agency awarded a $1,489,045 project grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research aims to investigate medical solutions for battlefield and other neurotrauma-related vision impairments. This 4-year award,...